HomeInsightsPE

Jenburkt Pharmaceuticals Ltd P/E Ratio

Jenburkt Pharmaceuticals Ltd P/E Ratio

download
stocks purchased

₹ 0.1 Cr

Volume transacted

stocks purchased

1.6 K

stocks traded

Last Updated time: 25 Jul 14:42 PM

Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

PE

14.8

Last updated : 25 Jul 14:42 PM

Key Highlights

    The P/E Ratio of Jenburkt Pharmaceuticals Ltd is 14.8 as of 25 Jul 14:42 PM .a1#The P/E Ratio of Jenburkt Pharmaceuticals Ltd changed from 11.7 on March 2019 to 11.7 on March 2024 . This represents a CAGR of 0.00% over 6 years. a1#The Latest Trading Price of Jenburkt Pharmaceuticals Ltd is ₹ 875.9 as of 25 Jul 14:32 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.3 to 27.3 in 5 years. This represents a CAGR of -0.72%a1# The PE Ratio of Automobile industry is 18.9. The PE Ratio of Finance industry is 23.5. The PE Ratio of IT - Software industry is 29.1. The PE Ratio of Pharmaceuticals industry is 38.6. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 24.3. In 2024a1#The Market Cap of Jenburkt Pharmaceuticals Ltd changed from ₹ 231.86 crore on March 2019 to ₹ 304.27 crore on March 2024 . This represents a CAGR of 4.63% over 6 years. a1#The Revenue of Jenburkt Pharmaceuticals Ltd changed from ₹ 32.27 crore to ₹ 40.03 crore over 8 quarters. This represents a CAGR of 11.38% a1#The EBITDA of Jenburkt Pharmaceuticals Ltd changed from ₹ 8.42 crore to ₹ 11.04 crore over 8 quarters. This represents a CAGR of 14.51% a1#The Net Pr of Jenburkt Pharmaceuticals Ltd changed from ₹ 5.95 crore to ₹ 7.88 crore over 8 quarters. This represents a CAGR of 15.08% a1#The Dividend Payout of Jenburkt Pharmaceuticals Ltd changed from 23.65 % on March 2019 to 25.97 % on March 2024 . This represents a CAGR of 1.57% over 6 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Jenburkt Pharmaceuticals Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Jenburkt Pharmaceuticals Ltd

Period
Mar '1911.7
Mar '209.8
Mar '2111.1
Mar '2211.7
Mar '2311.9
Mar '2411.7

Company Fundamentals for Jenburkt Pharmaceuticals Ltd

Market Cap

384 Cr

EPS

58.8

P/E Ratio (TTM) *

14.8

P/B Ratio (TTM) *

2.7

Day’s High

877.0

Day’s Low

867.0

DTE *

0.0

ROE *

17.9

52 Week High

925.0

52 Week Low

586.9

ROCE *

24.0

* All values are consolidated

Last Updated time: 25 Jul 14:42 PM

* All values are consolidated

Last Updated time: 25 Jul 14:42 PM

Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

PRICE

875.9

3.70 (0.42%)

stock direction

Last updated : 25 Jul 14:32

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Jenburkt Pharmaceuticals Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value of Jenburkt Pharmaceuticals Ltd

Market Value

385

Asset Value

112

2.4 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Jenburkt Pharmaceuticals Ltd14384
Sun Pharmaceuticals Industries Ltd38388,632
Cipla Ltd28121,443
Divis Laboratories Ltd75120,718
Zydus Lifesciences Ltd30118,680
Dr Reddys Laboratories Ltd20113,730

Key Valuation Metric of Jenburkt Pharmaceuticals Ltd

Earnings

25 Cr

14.8 X

PE Ratio

Market Cap

₹384.93Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

25 Cr

14.8 X

PE Ratio

Market Cap

₹384.93Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Jenburkt Pharmaceuticals Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Jenburkt Pharmaceuticals Ltd

Period
Mar '19232
Mar '20146
Mar '21183
Mar '22260
Mar '23294
Mar '24304

* All values are a in crore

×

Historical Revenue of Jenburkt Pharmaceuticals Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Jenburkt Pharmaceuticals Ltd

Period
Jun '2232
Sep '2237
Dec '2236
Mar '2336
Jun '2330
Sep '2339
Dec '2337
Mar '2440

* All values are a in crore

×

Historical EBITDA of Jenburkt Pharmaceuticals Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Jenburkt Pharmaceuticals Ltd

Period
Jun '228
Sep '2210
Dec '228
Mar '239
Jun '238
Sep '2310
Dec '239
Mar '2411

* All values are a in crore

×

Historical Net Profit of Jenburkt Pharmaceuticals Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Jenburkt Pharmaceuticals Ltd

Period
Jun '226
Sep '227
Dec '225
Mar '236
Jun '235
Sep '237
Dec '235
Mar '248

* All values are a in crore

×

Historical Dividend Payout of Jenburkt Pharmaceuticals Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Jenburkt Pharmaceuticals Ltd

Period
Mar '1924
Mar '2025
Mar '2128
Mar '2225
Mar '2326
Mar '2426

* All values are a in %

About Jenburkt Pharmaceuticals Ltd

About Jenburkt Pharmaceuticals Ltd

    Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe. The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements. In addition, it has a Research & Development unit duly approved by the Ministry of Science & Technology, Government of India. Hence, the Company has strong manufacturing facilities to cater to domestic and international market. The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work - Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company. In 2021-22, the Company launched a new OTC division ~ Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 2022-23.

Jenburkt Pharmaceuticals Ltd News Hub

News

Jenburkt Pharmaceuticals to declare Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2...

Read more

19 Jul 202410:24

News

Jenburkt Pharmaceuticals to conduct AGM

Jenburkt Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the compa...

Read more

24 Jun 202409:36

News

Board of Jenburkt Pharmaceuticals recommends final dividend

Jenburkt Pharmaceuticals announced that the Board of Directors of the Company at its meeti...

Read more

29 May 202410:57

News

Jenburkt Pharmaceuticals schedules board meeting

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2...

Read more

21 May 202415:36

News

Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6...

Read more

20 Jan 202412:45

News

Jenburkt Pharmaceuticals to table results

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7...

Read more

30 Oct 202314:04

Product Composition by Percentage (Revenue)

FAQs for PE of Jenburkt Pharmaceuticals Ltd

What is Jenburkt Pharmaceuticals Ltd current share price?

The current market price of Jenburkt Pharmaceuticals Ltd as of July 25, 2024 is ₹875.90.

What is Jenburkt Pharmaceuticals Ltd's market cap?

Jenburkt Pharmaceuticals Ltd's market capitalisation stood at ₹384 Cr as of July 25, 2024

What are Jenburkt Pharmaceuticals Ltd's total net assets?

According to Jenburkt Pharmaceuticals Ltd's most recent financial filings, the company's net assets total ₹112.1 Cr.

Is Jenburkt Pharmaceuticals Ltd making a profit or loss?

Jenburkt Pharmaceuticals Ltd's net Profit as of July 25, 2024 is close to ₹25 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199